DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma
[Background & Aims]: The class I- phosphatidylinositol-3 kinases (PI3Ks) signalling is dysregulated in almost all human cancers whereas the isoform-specific roles remain poorly investigated. We reported that the isoform δ (PI3Kδ) regulated epithelial cell polarity and plasticity and recent developments have heightened its role in hepatocellular carcinoma (HCC) and solid tumour progression. However, its role in cholangiocarcinoma (CCA) still lacks investigation.
[Approach & Results]: Immunohistochemical analyses of CCA samples reveal a high expression of PI3Kδ in the less differentiated CCA. The RT-qPCR and immunoblot analyses performed on CCA cells stably overexpressing PI3Kδ using lentiviral construction reveal an increase of mesenchymal and stem cell markers and the pluripotency transcription factors. CCA cells stably overexpressing PI3Kδ cultured in 3D culture display a thick layer of ECM at the basement membrane and a wide single lumen compared to control cells. Similar data are observed in vivo, in xenografted tumours established with PI3Kδ-overexpressing CCA cells in immunodeficient mice. The expression of mesenchymal and stemness genes also increases and tumour tissue displays necrosis and fibrosis, along with a prominent angiogenesis and lymphangiogenesis, as in mice liver of AAV8-based-PI3Kδ overexpression. These PI3Kδ-mediated cell morphogenesis and stroma remodelling were dependent on TGFβ/Src/Notch signalling. Whole transcriptome analysis of PI3Kδ using the cancer cell line encyclopedia allows the classification of CCA cells according to cancer progression.
[Conclusions]: Overall, our results support the critical role of PI3Kδ in the progression and aggressiveness of CCA via TGFβ/src/Notch-dependent mechanisms and open new directions for the classification and treatment of CCA patients., VBM was supported by A.S.C. s.a.r.l, Liban, LF receives financial support from ITMO Cancer of Aviesan within the 2021–2030 Cancer Control Strategy framework on funds administered by Inserm, INCa_16428, ANR-17-CE14-0013-01 and belongs to a team supported by the Fondation pour la Recherche Médicale (Equipe FRM 2020 no. EQU202003010517). AA is supported by the Fondation pour la Recherche Médicale (FRM SPF201809007054) and by Les Entreprises contre le Cancer Paris – Île-de-France (GEFLUC_2019). JV is the recipient of the following postdoctoral fellowships from the Spanish Association for the Study of the Liver (AEEH), the Fondation ARC (PDF2014601431) and the LABEX PLAS@PAR (Reference ANR-11-IDEX-0004-02). JV was funded by the Spanish Ministry for Science and Innovation (MCIN: ‘Ramón y Cajal’ Program RYC2021-034121-I). JV, EGS and LF are members of the European Network for the Study of Cholangiocarcinoma (ENSCCA) and participate in the initiative COST action EURO-CHOLANGIO-NET (CA18122). AGD is supported by funding from the La Ligue contre le Cancer., Peer reviewed
Proyecto:
AEI RYC2021-034121-I